Julien Dômont
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Sarcoma Diagnosis and Treatment, Gastrointestinal Tumor Research and Treatment, Soft tissue tumor case studies, Vascular Tumors and Angiosarcomas
Most-Cited Works
- → Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial(2012)1,303 cited
- → Lomustine and Bevacizumab in Progressive Glioblastoma(2017)960 cited
- → Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study(2012)736 cited
- → Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients(2017)498 cited
- → Impact of EGFR expression on colorectal cancer patient prognosis and survival(2004)461 cited
- → Desmoid-Type Fibromatosis: A Front-Line Conservative Approach to Select Patients for Surgical Treatment(2009)368 cited
- → Genomic Index of Sensitivity to Endocrine Therapy for Breast Cancer(2010)283 cited
- → Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis(2011)260 cited
- → Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial(2015)188 cited
- → CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence(2013)180 cited